SOUTH PLAINFIELD, NJ — (Marketwired) — 02/09/17 — (NASDAQ: COOL) today announced it has appointed Steve Gorlin to the Board of Directors. Mr. Gorlin has extensive experience building successful biotechnology companies, and is a leader in regenerative medicine, pharmaceutical drug and medical device research and development."We are extremely excited to announce Steve Gorlin as a new member of the PolarityTE Board of Directors. With over 40 successful years in the field, he remains a lea
SOUTH PLAINFIELD, NJ — (Marketwired) — 01/10/17 — (NASDAQ: COOL) following its previous announcement that it signed a definitive merger agreement with a Nevada corporation , (the "Merger") today announced that the Company–s name has been changed to PolarityTE, Inc., effective with The NASDAQ Capital Market at the open of business on January 11, 2017. The Company–s new CUSIP will be 731094108 and its common stock will continue to trade under the symbol "COOL.""Ch
SOUTH PLAINFIELD, NJ — (Marketwired) — 01/09/17 — (NASDAQ: COOL) following announcement that it had signed a definitive merger agreement with , (the "Merger") supplements its esteemed Clinical Board of Advisors with more innovative thought leaders in plastic and reconstructive surgery and regenerative medicine with Drs. Bentz, Bluebond-Langner, and Katz. Denver Lough MD, PhD, Chairman and CEO, remarked, "PolarityTE is focused on delivering transformative tissue engineering p
Dr. Neumeister has previously served as President of the Plastic Surgery Foundation, Plastic Surgery Research Council and a Leader in Translational Regenerative Medicine
Appoints Denver Lough, MD, PhD as Chief Executive Officer and Chairman of the Board; Appoints Edward Swanson, MD as Chief Operating Officer and Director; Executive Vice President John Stetson named Director; Majesco accepts subscription agreements for $2.25 million
